Levitee Labs Inc. — Regulatory Filings 2021

Jul 10, 2021

July 9, 2021

Canadian Securities Exchange British Columbia Securities Commission Alberta Securities Commission Nova Scotia Securities Commission Ontario Securities Commission Financial and Consumer Affairs Authority of Saskatchewan

Dear Sirs/Mesdames:

Re: Levitee Labs Inc. (Formerly Fibonacci Capital Corp.)

We refer to the prospectus of Levitee Labs Inc. (the “Corporation”) dated July 9, 2021 relating to qualifying the distribution of units of the Corporation, the common shares of the Corporation and common share purchase warrants.

We consent to being named and to the use in the above-mentioned prospectus, of our report dated July 9, 2021, to the Directors of Monk-E Nutraceuticals Inc. (the “Company”) on the following financial statements:

Statement of financial position as at September 30, 2020;

Statements of loss and comprehensive loss, changes in shareholders’ equity and cash flows for the period from May 24, 2020 (date of incorporation) to September 30, 2020, and notes to the financial statements, including a summary of significant accounting policies.

We report that we have read the prospectus and all information therein and have no reason to believe that there are any misrepresentations in the information contained therein that are derived from the financial statements upon which we have reported or that are within our knowledge as a result of our audit of such financial statements. We have complied with Canadian generally accepted standards for an auditor’s consent to the use of a report of the auditor included in an offering document, which does not constitute an audit or review of the prospectus as these terms are described in the CPA Canada Handbook – Assurance.

Sincerely,

==> picture [123 x 36] intentionally omitted <==

MNP LLP

Chartered Professional Accountants

encls.